JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$870M |
| 2 |
Meta Platforms (Facebook)
META
|
+$692M |
| 3 |
Johnson & Johnson
JNJ
|
+$495M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$408M |
| 5 |
Microsoft
MSFT
|
+$390M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$790M |
| 2 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$736M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$699M |
| 4 |
SLB Ltd
SLB
|
+$401M |
| 5 |
NWS
THE NEWS CORPORATION LTD CL-B
NWS
|
+$346M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.61% |
| 2 | Healthcare | 10.08% |
| 3 | Technology | 9.99% |
| 4 | Industrials | 9.18% |
| 5 | Consumer Discretionary | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZQK
926
DELISTED
QUICKSILVER,INC.
ZQK
| $37.7M | 0.01% |
5,359,086
+650,096
| +14% | +$4.06M |
|
|
DNY
927
DELISTED
DONNELLEY R R & SONS CO
DNY
| $37.7M | 0.01% |
2,386,587
+114,076
| +5% | +$1.8M |
|
|
TBI
928
Trueblue
TBI
$323M
| $37.5M | 0.01% |
1,563,138
+1,115,571
| +249% | +$27.9M |
|
929
Centene
CNC
$32.9B
| $37.5M | 0.01% |
2,343,764
+20,496
| +0.9% | +$295K |
|
|
DNB
930
DELISTED
Dun & Bradstreet
DNB
| $37.5M | 0.01% |
360,759
+36,763
| +11% | +$3.82M |
|
931
CALL
Pfizer
PFE
$154B
| $37.5M | 0.01% |
1,374,185
-186,453
| -12% | -$5.07M |
|
932
Quad
QUAD
$507M
| $37.4M | 0.01% |
1,231,748
-170,775
| -12% | -$5.04M |
|
|
NUVA
933
DELISTED
NuVasive, Inc.
NUVA
| $37.3M | 0.01% |
1,524,508
+432,460
| +40% | +$10.6M |
|
934
National CineMedia
NCMI
$370M
| $37.3M | 0.01% |
197,720
+191,860
| +3,274% | +$34.9M |
|
935
ITT
ITT
$18.9B
| $37.3M | 0.01% |
1,036,402
+673,632
| +186% | +$22.4M |
|
|
DYN
936
DELISTED
Dynegy, Inc.
DYN
| $37.1M | 0.01% |
1,920,425
-11,574
| -0.6% | -$235K |
|
|
ENV
937
DELISTED
ENVESTNET, INC.
ENV
| $37M | 0.01% |
1,194,494
-203,640
| -15% | -$5.65M |
|
|
AWAY
938
DELISTED
HOMEAWAY INC COM
AWAY
| $36.9M | 0.01% |
1,321,330
+50,855
| +4% | +$1.58M |
|
939
Spectrum Brands
SPB
$2.02B
| $36.8M | 0.01% |
559,471
+416,463
| +291% | +$25.4M |
|
|
PCYC
940
DELISTED
PHARMACYCLICS INC
PCYC
| $36.8M | 0.01% |
266,310
-156,219
| -37% | -$17.3M |
|
|
MTCN
941
DELISTED
ARCELORMITTAL 6% MANDATORILTY CONV SUB NT DUE 2016 (LUX)
MTCN
| $36.8M | 0.01% |
1,710,396
+1,343
| +0.1% | +$28.4K |
|
|
PRE
942
DELISTED
PARTNERRE LTD
PRE
| $36.7M | 0.01% |
401,081
+82,443
| +26% | +$7.39M |
|
943
Dollar Tree
DLTR
$24.9B
| $36.7M | 0.01% |
641,887
+163,632
| +34% | +$8.83M |
|
944
Standard BioTools
LAB
$310M
| $36.6M | 0.01% |
1,670,133
+162,060
| +11% | +$3.18M |
|
|
LSI
945
DELISTED
LSI CORPORATION
LSI
| $36.6M | 0.01% |
4,679,538
+2,716,569
| +138% | +$20.8M |
|
|
ANDV
946
DELISTED
Andeavor
ANDV
| $36.6M | 0.01% |
831,318
-4,441
| -0.5% | -$221K |
|
947
Vulcan Materials
VMC
$37B
| $36.5M | 0.01% |
705,139
+100,350
| +17% | +$4.96M |
|
948
Archrock
AROC
$5.81B
| $36.5M | 0.01% |
1,323,231
+185,700
| +16% | +$5.44M |
|
|
PEI
949
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
| $36.3M | 0.01% |
129,382
-65,766
| -34% | -$19.2M |
|
|
EVEP
950
DELISTED
EV Energy Partners, L.P.
EVEP
| $36.3M | 0.01% |
977,774
-46,676
| -5% | -$1.78M |
|
Similar funds
JP Morgan Chase's Q3 2013 Portfolio in Review
As of Q3 2013, JP Morgan Chase held 4,631 positions worth $337B, up 7.6% from $314B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
JP Morgan Chase deployed $12B of net new capital in Q3 2013, opening 262 new positions and adding to 1,958 existing holdings. Its largest new stake was Twenty-First Century Fox, Inc. Class B: 9,682,912 shares worth $323M.
By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was COVIDIEN PLC COM SHS NEW (IRELAND), an estimated $790M trimmed.
- JP Morgan Chase's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class B: 9,682,912 shares worth $323M.
- JP Morgan Chase added most to iShares MSCI EAFE ETF in Q3 2013, an estimated $870M increase.
- JP Morgan Chase's biggest Q3 2013 reduction was COVIDIEN PLC COM SHS NEW (IRELAND), cutting an estimated $790M.
- JP Morgan Chase fully exited THE NEWS CORPORATION LTD CL-B in Q3 2013, selling an estimated $346M.
- JP Morgan Chase's ten largest holdings make up 15% of its $337B portfolio in Q3 2013.
- JP Morgan Chase opened 262 new positions and closed 269 in Q3 2013.
- JP Morgan Chase's portfolio value rose 7.6% quarter-over-quarter to $337B.
Based on JP Morgan Chase's 13F filing for Q3 2013, filed 31 Oct 2013.